{"database": "lobbying", "table": "lobbying_activities", "rows": [[2829229, "b56fa0ba-e58b-4341-b1a5-60efab79a1e4", "Q2", "RUBICON ADVISORS, LLC", 315091, "ASCENDIS PHARMA, INC.", 2022, "second_quarter", "PHA", "Food and Drug Administration, Orphan Drugs", "Food & Drug Administration (FDA)", 60000, null, 0, 0, "2022-07-19T11:58:09-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2829229"], "units": {}, "query_ms": 1.3947139959782362, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}